Global cryo leader Target biopharma, cell and gene therapy, IVF, cord blood, stem cell banks, hospitals and research facilities leveraging MVE’s established position in cryogenic storage and shipping to upsell premium storage solutions, consumables, and service contracts.

Expansion opportunities Capitalize on Cryoport acquisition history to position MVE as a stable, integrated cryogenic solutions partner for large pharma and government labs seeking end-to-end cold chain and backup storage, offering bundled hardware, monitoring software, and validation services.

Tech-enabled value Leverage tech stack strengths (AWS, HubSpot, Python, data analytics) to offer IoT-enabled temperature monitoring, remote diagnostics, predictive maintenance, and enhanced compliance reporting to customers with stringent biobanking standards.

Growth fit customers Align with mid-market to enterprise buyers at biobanks, IVF centers, and contract research organizations that match MVE’s revenue profile and 50–200 employee scale for scalable storage solutions, service agreements, and training packages.

Awards and credibility Highlight historical awards such as ISBER Outstanding New Product to build trust with procurement teams and government/academic buyers, using case studies and testimonials to unlock pilots, trials, and longer-term procurement contracts.